What Is the Best Multivitamin for Eye Health?
The best pick for eye health is PreserVision AREDS 2 (120 softgels): 2 softgels a day give 10 mg of lutein and 2 mg of zeaxanthin, the amounts tested in the AREDS2 trial. We checked four eye formulas against those amounts, priced November 20, 2026.
By Erin Rose Updated November 2026 How we score
1. Our pick
- Takes a day
- 2 softgels60 servings in the pack
- Cost
- $0.52 a day$30.99 for the pack
- Lutein and zeaxanthin
- The AREDS2 amountsA day; NIH label 246688
Why we pick it Its label gives the lutein and zeaxanthin amounts the AREDS2 trial tested. It costs the least a day of the two that reach those amounts. It is an eye-vitamin formula, not a daily multivitamin: the label lists vitamins C and E, zinc, copper, lutein and zeaxanthin, and no vitamin D, B12 or folate.
Ocuvite Eye Health Softgels costs $0.33 a day, against $0.52 for PreserVision AREDS 2 (120 softgels), but gives 5 mg lutein, 1 mg zeaxanthin, under the AREDS2 amounts.
2. One softgel a day: Ocuvite Eye Health Softgels
- Takes a day
- 1 softgel30 servings in the pack
- Cost
- $0.33 a day$9.96 for the pack
Its label gives less lutein and zeaxanthin than the AREDS2 amounts.
3. The same amounts, bigger bottle: PreserVision AREDS 2 (130 softgels)
- Takes a day
- 2 softgels65 servings in the pack
- Cost
- —price not shown for the pack
Its label gives the same lutein and zeaxanthin as our pick, the AREDS2 amounts.
The other eye formulas
4. A gummy: Ocuvite Eye Vitamin & Mineral Gummies
Ocuvite Eye Vitamin & Mineral Gummies takes 2 gummies a day. The pack has 30 servings. Its label gives less lutein and zeaxanthin than the AREDS2 amounts. It costs $0.70 a day.
Ocuvite Eye Vitamin & Mineral Gummies
Check price on AmazonFour eye formulas, side by side
Two of the four reach the lutein and zeaxanthin amounts the AREDS2 trial tested. Our pick comes first, then the rest from the lowest cost a day.
| Eye formula | Takes a day | Cost a day | Lutein and zeaxanthin a day | Zinc a day | Buy |
|---|---|---|---|---|---|
PreserVision AREDS 2 (120 softgels)Our pick60 servings | 2 softgels | $0.52 | 10 mg and 2 mg, the AREDS2 amounts | 80 mg | See on Amazon |
Ocuvite Eye Health Softgels30 servings | 1 softgel | $0.33 | 5 mg and 1 mg | 9 mg | See on Amazon |
PreserVision AREDS 2 (130 softgels)65 servings | 2 softgels | price not shown | 10 mg and 2 mg, the AREDS2 amounts | 80 mg | See on Amazon |
Ocuvite Eye Vitamin & Mineral Gummies30 servings | 2 gummies | $0.70 | 5 mg and 1 mg | 9 mg | See on Amazon |
Questions about eye vitamins
What did the AREDS2 trial test?
AREDS2 enrolled 4,203 people aged 50 to 85 at risk of advanced age-related macular degeneration. It tested lutein and zeaxanthin added to the AREDS formula, and followed them for a median of 5 years.
Did lutein and zeaxanthin lower the chance of advanced macular degeneration?
Not by a statistically significant amount in the main analyses: the hazard ratio was 0.90 (98.7% confidence interval 0.76 to 1.07). The trial also tested lower zinc doses and found no apparent effect on progression.
How much zinc is in these eye vitamins?
PreserVision AREDS 2 (120 softgels) gives 80 mg a day on its label. NIH’s upper limit for zinc from supplements is 40 mg.
How we checked
We took the eye formulas shoppers ask about that Amazon sold on November 20, 2026, and read each label’s lutein, zeaxanthin and zinc for a day’s serving in NIH’s label database. We compared lutein and zeaxanthin with the amounts the AREDS2 trial tested, as its abstract reports them. Prices are Amazon’s. This page compares labels; it does not say a product treats an eye condition. For daily multivitamins, see the best multivitamin, best for men over 50 and best for women over 50. More in our multivitamin guides.
Sources
- Labels: NIH Dietary Supplement Label Database, label ids 246688, 237021, 270553, 270550. Prices: Amazon listings, November 20, 2026.
- Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA, 2013 May 15. PubMed 23644932.


